China rolls out first one-jab COVID-19 vaccine, rival to US’s Johnson & Johnson

0

Beijing: China has given conditional approval for a single dose COVID-19 vaccine, touted to be a rival to Johnson & Johnson’s one-jab shot cleared by the US drug regulator on Sunday (February 28).
China’s first Ad5-nCoV COVID-19 vaccine was rolled out on Friday, the state-run Global Times reported on Sunday.
Phase-I clinical trials of the vaccine started on March 16, last year, making it the world’s first COVID-19 candidate vaccine that entered clinical trials, it said.
It is the only single-dose COVID-19 vaccine that has been given conditional approval to be rolled out in China, the report quoted last Friday’s story by the state broadcaster China Central Television (CCTV).

LEAVE A REPLY